Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mancini

Showing results (781-790 of 794) with videos related to

Pageof 80
Sort By:
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 13, 2016
The NHLBI REVIVE-IT study: Understanding its discontinuation in the context of current left ventricular assist device therapyFrancis D Pagani, Keith D Aaronson, Robert Kormos, et al.
Leukemia|February 8, 2014
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibitionM R Sapienza, F Fuligni, C Agostinelli, et al.
Transplantation|October 3, 1999
Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine--results at six months after transplantationH J Eisen, R E Hobbs, S F Davis, et al.
Transplantation|February 24, 2001
Safety, tolerability, and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil-based formulation of cyclosporine--results at 24 months after transplantationH J Eisen, R E Hobbs, S F Davis, et al.
Leukemia|July 1, 2017
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosisG Martinelli, M Mancini, C De Benedittis, et al.
Journal of the American College of Cardiology|May 18, 2019
Pacemaker Implantation After Mitral Valve Surgery With Atrial Fibrillation AblationJoseph J DeRose, Donna M Mancini, Helena L Chang, et al.
Human Mutation|February 1, 2011
MLL2 mutation spectrum in 45 patients with Kabuki syndromeAimée D C Paulussen, Alexander P A Stegmann, Marinus J Blok, et al.
JAMA|March 27, 2019
Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure: A Randomized Clinical TrialTerrence M Yau, Francis D Pagani, Donna M Mancini, et al.
Circulation. Heart Failure|April 5, 2021
Characteristics and Outcomes of COVID-19 in Patients on Left Ventricular Assist Device SupportEdo Y Birati, Samer S Najjar, Ryan J Tedford, et al.
American Journal of Human Genetics|February 3, 2016
De Novo Loss-of-Function Mutations in USP9X Cause a Female-Specific Recognizable Syndrome with Developmental Delay and Congenital MalformationsMargot R F Reijnders, Vasilios Zachariadis, Brooke Latour, et al.
Pageof 80

Showing results (781-790 of 794) with videos related to

Sort By:
Pageof 80
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 13, 2016
The NHLBI REVIVE-IT study: Understanding its discontinuation in the context of current left ventricular assist device therapyFrancis D Pagani, Keith D Aaronson, Robert Kormos, et al.
Leukemia|February 8, 2014
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibitionM R Sapienza, F Fuligni, C Agostinelli, et al.
Transplantation|October 3, 1999
Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine--results at six months after transplantationH J Eisen, R E Hobbs, S F Davis, et al.
Transplantation|February 24, 2001
Safety, tolerability, and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil-based formulation of cyclosporine--results at 24 months after transplantationH J Eisen, R E Hobbs, S F Davis, et al.
Leukemia|July 1, 2017
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosisG Martinelli, M Mancini, C De Benedittis, et al.
Journal of the American College of Cardiology|May 18, 2019
Pacemaker Implantation After Mitral Valve Surgery With Atrial Fibrillation AblationJoseph J DeRose, Donna M Mancini, Helena L Chang, et al.
Human Mutation|February 1, 2011
MLL2 mutation spectrum in 45 patients with Kabuki syndromeAimée D C Paulussen, Alexander P A Stegmann, Marinus J Blok, et al.
JAMA|March 27, 2019
Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure: A Randomized Clinical TrialTerrence M Yau, Francis D Pagani, Donna M Mancini, et al.
Circulation. Heart Failure|April 5, 2021
Characteristics and Outcomes of COVID-19 in Patients on Left Ventricular Assist Device SupportEdo Y Birati, Samer S Najjar, Ryan J Tedford, et al.
American Journal of Human Genetics|February 3, 2016
De Novo Loss-of-Function Mutations in USP9X Cause a Female-Specific Recognizable Syndrome with Developmental Delay and Congenital MalformationsMargot R F Reijnders, Vasilios Zachariadis, Brooke Latour, et al.
Pageof 80